These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2956236)

  • 21. Genetically determined myocarditis: clinical presentation and immunological characteristics.
    Caforio AL; Iliceto S
    Curr Opin Cardiol; 2008 May; 23(3):219-26. PubMed ID: 18382209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion of specific alphabeta+ T-cell subsets in the myocardium of patients with myocarditis and idiopathic dilated cardiomyopathy associated with Coxsackievirus B infection.
    Luppi P; Rudert W; Licata A; Riboni S; Betters D; Cotrufo M; Frati G; Condorelli G; Trucco M
    Hum Immunol; 2003 Feb; 64(2):194-210. PubMed ID: 12559622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on lymphocyte subsets and NK cell function in patients with dilated cardiomyopathy.
    Yamakawa K; Fukuta S; Yoshinaga T; Umemoto S; Itagaki T; Kusukawa R
    Jpn Circ J; 1986 Dec; 50(12):1259-63. PubMed ID: 2950255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiomyopathy and myocarditis--a review of new aspects in research in West Germany.
    Maisch B; Izumi T
    Heart Vessels Suppl; 1985; 1():8-13. PubMed ID: 2956241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.
    Kawai C
    Circulation; 1999 Mar; 99(8):1091-100. PubMed ID: 10051305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune cytotoxic mechanism of myocardial lesion in non-specific myocarditis and idiopathic congestive cardiomyopathy.
    Zimin YuI ; Sumarokov AV; Tereshchenko SE
    Cor Vasa; 1988; 30(2):127-34. PubMed ID: 3391036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-mediated cytotoxicity in hearts with dilated cardiomyopathy: correlation with interstitial fibrosis and foci of activated T lymphocytes.
    Badorff C; Noutsias M; Kühl U; Schultheiss HP
    J Am Coll Cardiol; 1997 Feb; 29(2):429-34. PubMed ID: 9015000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological status and pathology of coxsackie B viral myocarditis and dilated cardiomyopathy.
    Chen SX; Mei SW; Bao SH; Zheng XJ; Chang PL; Yao JS; Yao S; Zhang DQ
    Chin Med J (Engl); 1993 Sep; 106(9):659-64. PubMed ID: 8287699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of enteroviral RNA in endomyocardial biopsies in inflammatory cardiomyopathy and idiopathic dilated cardiomyopathy].
    Pauschinger M; Kühl U; Dörner A; Schieferecke K; Petschauer S; Rauch U; Schwimmbeck PL; Kandolf R; Schultheiss HP
    Z Kardiol; 1998 Jun; 87(6):443-52. PubMed ID: 9691414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemistry in dilated cardiomyopathy.
    Kühl U; Noutsias M; Schultheiss HP
    Eur Heart J; 1995 Dec; 16 Suppl O():100-6. PubMed ID: 8682073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dilated myocarditis and cardiomyopathies. The dysimmune hypothesis].
    Sachs RN
    Arch Mal Coeur Vaiss; 1990 Mar; 83(3):407-11. PubMed ID: 2108636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocarditis and dilated cardiomyopathy: an inflammatory link.
    Mason JW
    Cardiovasc Res; 2003 Oct; 60(1):5-10. PubMed ID: 14522402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy].
    Lauer B; Padberg K; Schultheiss HP; Strauer BE
    Z Kardiol; 1995 Apr; 84(4):301-10. PubMed ID: 7785303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocarditis and cardiomyopathy.
    Kereiakes DJ; Parmley WW
    Am Heart J; 1984 Nov; 108(5):1318-26. PubMed ID: 6093491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy.
    Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S
    G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistological characterization of infiltrating lymphocytes in biopsies of patients with clinically suspected dilated cardiomyopathy.
    Kühl U; Seeberg B; Schultheiss HP; Strauer BE
    Eur Heart J; 1994 Aug; 15 Suppl C():62-7. PubMed ID: 7995272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance.
    Caforio AL; Mahon NJ; Tona F; McKenna WJ
    Eur J Heart Fail; 2002 Aug; 4(4):411-7. PubMed ID: 12167378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relation between helper and suppressive/cytotoxic T lymphocytes in the peripheral blood in patients with dilated cardiomyopathy].
    Smalcelj A; Duraković Z; Batinić D; Bogdan I; Grgić V
    Acta Med Iugosl; 1991; 45(1):3-13. PubMed ID: 1827936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The relation of myocarditis to the development of cardiomyopathy].
    Kováliková V; Gvozdják J
    Vnitr Lek; 1989 Apr; 35(4):352-7. PubMed ID: 2741354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis.
    Huber SA
    Curr Pharm Des; 2016; 22(4):408-26. PubMed ID: 26696257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.